Ionis Pharmaceuticals paid its 6 named executives $30.8M in total in FY2025 (Dec). CEO Brett P. Monia was paid $13.4M of that.
Pay$100 in the stock at the end of FY20 → $163
Pay of each named executive
Brett P. MoniaChief Executive Officer
| FY2025 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2021 (Dec) | Not disclosed |
3 years
Elizabeth L. HougenEVP, Finance and Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Richard S. GearyEVP, Chief Development Officer
| FY2025 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Brian BirchlerEVP, Corporate and Development Operations
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Eric SwayzeEVP, Research
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Patrick R. O’NeilEVP, Chief Legal Officer and General Counsel
| FY2025 (Dec) | Not disclosed | ||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.